Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Psychiatric symptoms can be early signs of systemic lupus erythematosus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

More skin lesions in lupus patients may indicate higher disease activity.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.